{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:01:08Z","timestamp":1790208068532,"version":"4.1.0"},"reference-count":134,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1003252","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T17:24:20Z","timestamp":1599153860000},"page":"e1003252","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":97,"title":["COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1897-1978","authenticated-orcid":true,"given":"Nicholas J.","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5524-0325","authenticated-orcid":true,"given":"James A.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5322-912X","authenticated-orcid":true,"given":"Richard M.","family":"Hoglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9941-6975","authenticated-orcid":true,"given":"Xin Hui S.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phaik Yeong","family":"Cheah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4566-4030","authenticated-orcid":true,"given":"Joel","family":"Tarning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"issue":"2","key":"pmed.1003252.ref001","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4269\/ajtmh.1963.12.121","article-title":"Pitfalls in a discovery: the chronicle of chloroquine","volume":"12","author":"GR Coatney","year":"1963","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"issue":"3","key":"pmed.1003252.ref002","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1172\/JCI101980","article-title":"Studies on the chemotherapy of the human malarias. VI. The physiological disposition, antimalarial activity, and toxicity of several derivatives of 4-aminoquinoline","volume":"27","author":"RW Berliner","year":"1948","journal-title":"The Journal of clinical investigation"},{"key":"pmed.1003252.ref003","volume-title":"Advances in malaria chemotherapy: report of a WHO scientific group","author":"World Health Organisation Scientific Group on the Chemotherapy of Malaria","year":"1984"},{"key":"pmed.1003252.ref004","unstructured":"CEIC. China CN production. 2020 [cited 2020 May 20]. Available from: https:\/\/www.ceicdata.com\/en\/china\/pharmaceutical-production-ytd-antiparasitics-vitamins-and-minerals\/cn-production-ytd-hydroxychloroquine."},{"key":"pmed.1003252.ref005","volume-title":"Guidelines for the treatment of malaria","author":"World Health Organization","year":"2015"},{"issue":"2","key":"pmed.1003252.ref006","first-page":"209","article-title":"Chloroquine prophylaxis against vivax malaria in pregnancy: a randomized, double-blind, placebo-controlled trial. Tropical Medicine &","volume":"12","author":"L Villegas","year":"2007","journal-title":"International Health"},{"issue":"5","key":"pmed.1003252.ref007","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1473-3099(11)70339-5","article-title":"Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study","volume":"12","author":"R McGready","year":"2012","journal-title":"The Lancet Infectious Diseases"},{"issue":"4","key":"pmed.1003252.ref008","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0002-9343(88)90357-9","article-title":"Hydroxychloroquine treatment of rheumatoid arthritis","volume":"85","author":"RI Rynes","year":"1988","journal-title":"The American Journal of Medicine"},{"issue":"1","key":"pmed.1003252.ref009","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0002-9343(83)91265-2","article-title":"Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate","volume":"75","author":"EW McChesney","year":"1983","journal-title":"The American Journal of Medicine"},{"issue":"3","key":"pmed.1003252.ref010","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0002-9343(49)90167-9","article-title":"The treatment of hepatic amebiasis with chloroquine","volume":"6","author":"NJ Conan","year":"1949","journal-title":"The American journal of medicine"},{"issue":"3","key":"pmed.1003252.ref011","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0041-008X(67)90089-0","article-title":"Tissue distribution of chloroquine, hydroxychloroquine, and desethylchloroquine in the rat","volume":"10","author":"EW McChesney","year":"1967","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"2","key":"pmed.1003252.ref012","first-page":"323","article-title":"The metabolism of chloroquine in man during and after repeated oral dosage","volume":"158","author":"E McChesney","year":"1967","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"pmed.1003252.ref013","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1365-2125.1983.tb01532.x","article-title":"Disposition of chloroquine in man after single intravenous and oral doses","volume":"15","author":"L Gustafsson","year":"1983","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"4","key":"pmed.1003252.ref014","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF00542151","article-title":"The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects","volume":"26","author":"M Frisk-Holmberg","year":"1984","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"5","key":"pmed.1003252.ref015","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2125.1986.tb02935.x","article-title":"Comparison of the pharmacokinetics of chloroquine after single intravenous and intramuscular administration in healthy Africans","volume":"22","author":"AF Aderounmu","year":"1986","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"pmed.1003252.ref016","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2125.1986.tb02876.x","article-title":"Cardiovascular toxicity and distribution kinetics of intravenous chloroquine","volume":"22","author":"S Looareesuwan","year":"1986","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"3","key":"pmed.1003252.ref017","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2125.1987.tb03048.x","article-title":"The disposition of chloroquine in healthy Nigerians after single intravenous and oral doses","volume":"23","author":"O Walker","year":"1987","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"2","key":"pmed.1003252.ref018","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/infdis\/155.2.192","article-title":"Parenteral chloroquine for treating falciparum malaria","volume":"155","author":"N White","year":"1987","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"pmed.1003252.ref019","first-page":"879","article-title":"Chloroquine and desethylchloroquine concentrations during regular long-term malaria prophylaxis","volume":"65","author":"L Rombo","year":"1987","journal-title":"Bulletin of the World Health Organization"},{"issue":"23","key":"pmed.1003252.ref020","first-page":"1493","volume":"319","author":"NJ White","year":"1988","journal-title":"Chloroquine Treatment of Severe Malaria in Children. New England Journal of Medicine"},{"issue":"3","key":"pmed.1003252.ref021","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1128\/AAC.35.3.406","article-title":"Efficacy of a loading dose of oral chloroquine in a 36-hour treatment schedule for uncomplicated Plasmodium falciparum malaria","volume":"35","author":"E Pussard","year":"1991","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"6","key":"pmed.1003252.ref022","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1365-2125.1995.tb05731.x","article-title":"The pharmacokinetics of three multiple dose regimens of chloroquine: implications for malaria chemoprophylaxis","volume":"39","author":"J Wetsteyn","year":"1995","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"10","key":"pmed.1003252.ref023","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/s00228-008-0500-z","article-title":"Chloroquine pharmacokinetics in pregnant and nonpregnant women with vivax malaria","volume":"64","author":"SJ Lee","year":"2008","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"6","key":"pmed.1003252.ref024","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1128\/AAC.02794-13","article-title":"Pharmacokinetic interactions between primaquine and chloroquine","volume":"58","author":"S Pukrittayakamee","year":"2014","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"11","key":"pmed.1003252.ref025","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1093\/jac\/dky297","article-title":"Enantiospecific pharmacokinetics and drug\u2013drug interactions of primaquine and blood-stage antimalarial drugs","volume":"73","author":"K Chairat","year":"2018","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"1","key":"pmed.1003252.ref026","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12936-016-1181-1","article-title":"Population pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border","volume":"15","author":"R H\u00f6glund","year":"2016","journal-title":"Malaria Journal"},{"issue":"5","key":"pmed.1003252.ref027","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1177\/0961203317727601","article-title":"Steady-state pharmacokinetics of hydroxychloroquine in patients with cutaneous lupus erythematosus","volume":"27","author":"H Al-Rawi","year":"2018","journal-title":"Lupus"},{"issue":"4","key":"pmed.1003252.ref028","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s40262-018-0712-z","article-title":"Pharmacokinetics of Hydroxychloroquine in Pregnancies with Rheumatic Diseases","volume":"58","author":"SJ Balevic","year":"2019","journal-title":"Clinical Pharmacokinetics"},{"key":"pmed.1003252.ref029","article-title":"In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)","author":"X Yao","year":"2020","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"pmed.1003252.ref030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2125.1988.tb05281.x","article-title":"A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers","volume":"26","author":"S Tett","year":"1988","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"3","key":"pmed.1003252.ref031","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/rheumatology\/33.3.235","article-title":"Bioavailability of hydroxychloroquine tablets in patients with rheumatoid arthritis.","volume":"33","author":"A McLachlan","year":"1994","journal-title":"Rheumatology"},{"issue":"1","key":"pmed.1003252.ref032","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/0961203396005001041","article-title":"Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases","volume":"5","author":"DE Furst","year":"1996","journal-title":"Lupus"},{"issue":"3","key":"pmed.1003252.ref033","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2125.1996.tb00190.x","article-title":"Hydroxychloroquine relative bioavailability: within subject reproducibility","volume":"41","author":"S Tett","year":"1996","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"7","key":"pmed.1003252.ref034","first-page":"1656","article-title":"Concentration-effect relationship of hydroxychloroquine in patients with rheumatoid arthritis\u2013a prospective, dose ranging study","volume":"27","author":"S Tett","year":"2000","journal-title":"The Journal of Rheumatology"},{"issue":"6","key":"pmed.1003252.ref035","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00007691-200312000-00005","article-title":"Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis","volume":"25","author":"SJ Carmichael","year":"2003","journal-title":"Therapeutic drug monitoring"},{"issue":"4","key":"pmed.1003252.ref036","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1128\/AAC.00339-08","article-title":"Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by Plasmodium vivax","volume":"53","author":"HS Lim","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"8","key":"pmed.1003252.ref037","first-page":"2176","article-title":"Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus. Arthritis &","volume":"67","author":"M Jallouli","year":"2015","journal-title":"Rheumatology"},{"issue":"2","key":"pmed.1003252.ref038","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/FTD.0000000000000261","article-title":"Population pharmacokinetics of hydroxychloroquine in Japanese patients with cutaneous or systemic lupus erythematosus","volume":"38","author":"S Morita","year":"2016","journal-title":"Therapeutic Drug Monitoring"},{"issue":"1","key":"pmed.1003252.ref039","first-page":"184","article-title":"Association of polymorphisms of cytochrome P450 2D6 with blood hydroxychloroquine levels in patients with systemic lupus erythematosus. Arthritis &","volume":"68","author":"JY Lee","year":"2016","journal-title":"Rheumatology"},{"issue":"4","key":"pmed.1003252.ref040","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/acr.22962","article-title":"Factors related to blood hydroxychloroquine concentration in patients with systemic lupus erythematosus","volume":"69","author":"J Yeon Lee","year":"2017","journal-title":"Arthritis Care & Research"},{"issue":"5","key":"pmed.1003252.ref041","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2165\/00003088-199325050-00005","article-title":"Clinical pharmacokinetics of slow-acting antirheumatic drugs","volume":"25","author":"SE Tett","year":"1993","journal-title":"Clinical Pharmacokinetics"},{"issue":"4","key":"pmed.1003252.ref042","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jpba.2004.11.048","article-title":"Enantioselective analysis of the metabolites of hydroxychloroquine and application to an in vitro metabolic study","volume":"37","author":"CD Cardoso","year":"2005","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"issue":"1","key":"pmed.1003252.ref043","first-page":"93","article-title":"In vitro activity of chloroquine, the two enantiomers of chloroquine, desethylchloroquine and pyronaridine against Plasmodium falciparum","volume":"22","author":"S Fu","year":"1986","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"7","key":"pmed.1003252.ref044","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/jmv.25440","article-title":"Antimalarial drugs and their metabolites are potent Zika virus inhibitors","volume":"91","author":"Y Han","year":"2019","journal-title":"Journal of Medical Virology"},{"issue":"8316","key":"pmed.1003252.ref045","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0140-6736(83)91770-1","article-title":"Pitfalls in the measurement of chloroquine concentrations","volume":"321","author":"L Gustafsson","year":"1983","journal-title":"The Lancet"},{"issue":"1","key":"pmed.1003252.ref046","first-page":"1","article-title":"Detection and determination of antimalarial drugs and their metabolites in body fluids. Journal of Chromatography B","volume":"434","author":"Y Bergqvist","year":"1988","journal-title":"Biomedical Sciences and Applications"},{"issue":"9","key":"pmed.1003252.ref047","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3109\/15563650.2010.518969","article-title":"Blood concentrations are better predictors of chloroquine poisoning severity than plasma concentrations: a prospective study with modeling of the concentration\/effect relationships","volume":"48","author":"B M\u00e9garbane","year":"2010","journal-title":"Clinical Toxicology"},{"issue":"1","key":"pmed.1003252.ref048","first-page":"139","article-title":"Sensitive high-performance liquid chromatographic analysis for chloroquine in body fluids application to studies of drug resistance in Plasmodium falciparum. Journal of Chromatography B","volume":"225","author":"MA Staiger","year":"1981","journal-title":"Biomedical Sciences and Applications"},{"issue":"6","key":"pmed.1003252.ref049","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1124\/dmd.31.6.748","article-title":"In vitro metabolism of chloroquine: identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation","volume":"31","author":"D Projean","year":"2003","journal-title":"Drug Metabolism and Disposition"},{"issue":"11","key":"pmed.1003252.ref050","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: an old drug against today's diseases","volume":"3","author":"A Savarino","year":"2003","journal-title":"The Lancet Infectious Diseases"},{"issue":"4","key":"pmed.1003252.ref051","doi-asserted-by":"crossref","first-page":"105932","DOI":"10.1016\/j.ijantimicag.2020.105932","article-title":"Chloroquine and hydroxychloroquine as available weapons to fight COVID-19","volume":"55","author":"P Colson","year":"2020","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"1","key":"pmed.1003252.ref052","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","volume":"56","author":"P Gautret","year":"2020","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"1","key":"pmed.1003252.ref053","first-page":"1","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"J Liu","journal-title":"Cell Discovery. 2020"},{"issue":"3","key":"pmed.1003252.ref054","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"M Wang","year":"2020","journal-title":"Cell Research"},{"issue":"2","key":"pmed.1003252.ref055","doi-asserted-by":"crossref","first-page":"106020","DOI":"10.1016\/j.ijantimicag.2020.106020","article-title":"Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal","volume":"56","author":"J Fantini","year":"2020","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"1","key":"pmed.1003252.ref056","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.chom.2019.06.001","article-title":"Elucidating mechanisms of drug-resistant Plasmodium falciparum","volume":"26","author":"LS Ross","year":"2019","journal-title":"Cell Host & Microbe"},{"issue":"5","key":"pmed.1003252.ref057","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1179\/135100003225002907","article-title":"Glutathione is involved in the antimalarial action of chloroquine and its modulation affects drug sensitivity of human and murine species of Plasmodium","volume":"8","author":"H Ginsburg","year":"2003","journal-title":"Redox Report"},{"issue":"6","key":"pmed.1003252.ref058","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2165\/00002018-199512060-00003","article-title":"CNS adverse events associated with antimalarial agents","volume":"12","author":"PA Phillips-Howard","year":"1995","journal-title":"Drug Safety"},{"issue":"3","key":"pmed.1003252.ref059","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1708-8305.1996.tb00729.x","article-title":"Malaria chemoprophylaxis in German tourists: a prospective study on compliance and adverse reactions","volume":"3","author":"D Huzly","year":"1996","journal-title":"Journal of travel medicine"},{"issue":"2","key":"pmed.1003252.ref060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2310\/7060.2000.00026","article-title":"Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chemoprophylaxis against malaria in Danish travelers","volume":"7","author":"E Petersen","year":"2000","journal-title":"Journal of Travel Medicine"},{"issue":"1","key":"pmed.1003252.ref061","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/00002018-200427010-00003","article-title":"Antimalarial drug toxicity","volume":"27","author":"WRJ Taylor","year":"2004","journal-title":"Drug Safety"},{"issue":"3","key":"pmed.1003252.ref062","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/14740338.2017.1269168","article-title":"Hydroxychloroquine in systemic lupus erythematosus (SLE)","volume":"16","author":"C Ponticelli","year":"2017","journal-title":"Expert Opinion on Drug Safety"},{"issue":"4","key":"pmed.1003252.ref063","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF00316467","article-title":"Abnormal circulatory control in falciparum malaria: the effects of antimalarial drugs","volume":"44","author":"W Supanaranond","year":"1993","journal-title":"European Journal of Clinical Pharmacology"},{"key":"pmed.1003252.ref064","author":"World Health Organization","year":"2017","journal-title":"WHO Evidence Review Group on the Cardiotoxicity of Antimalarial Medicines"},{"issue":"8","key":"pmed.1003252.ref065","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1473-3099(07)70187-1","article-title":"Cardiotoxicity of antimalarial drugs","volume":"7","author":"NJ White","year":"2007","journal-title":"The Lancet Infectious Diseases"},{"issue":"1","key":"pmed.1003252.ref066","first-page":"437","article-title":"Blockade of currents by the antimalarial drug chloroquine in feline ventricular myocytes","volume":"297","author":"JA S\u00e1nchez-Chapula","year":"2001","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"pmed.1003252.ref067","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/adt.2018.882","article-title":"Electrophysiological and pharmacological characterization of human inwardly rectifying Kir2. 1 channels on an automated patch-clamp platform","volume":"17","author":"C Sanson","year":"2019","journal-title":"Assay and Drug Development Technologies"},{"issue":"10","key":"pmed.1003252.ref068","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.hrthm.2015.05.027","article-title":"Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current If: Novel electrophysiological insights and therapeutic potential","volume":"12","author":"RA Capel","year":"2015","journal-title":"Heart Rhythm"},{"issue":"4","key":"pmed.1003252.ref069","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1073\/pnas.0708153105","article-title":"The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel","volume":"105","author":"AA Rodrguez-Menchaca","year":"2008","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"pmed.1003252.ref070","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/15563650500514558","article-title":"Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia","volume":"44","author":"CY Chen","year":"2006","journal-title":"Clinical Toxicology"},{"key":"pmed.1003252.ref071","first-page":"1213","volume-title":"Mayo Clinic Proceedings","author":"JR Giudicessi","year":"2020"},{"issue":"1","key":"pmed.1003252.ref072","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12916-018-1188-2","article-title":"The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review","volume":"16","author":"IL Haeusler","year":"2018","journal-title":"BMC Medicine"},{"issue":"1","key":"pmed.1003252.ref073","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1128\/AAC.01111-08","article-title":"Chloroquine is grossly overdosed and overused but well tolerated in Guinea-Bissau","volume":"53","author":"J Ursing","year":"2009","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"4","key":"pmed.1003252.ref074","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/cpt.1303","article-title":"Assessment of Multi-Ion Channel Block in a Phase I Randomized Study Design: Results of the CIPA Phase I ECG Biomarker Validation Study","volume":"105","author":"J Vicente","year":"2019","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"pmed.1003252.ref075","article-title":"Chloroquine-induced torsade de pointes in a COVID-19 patient","author":"Y Szekely","year":"2020","journal-title":"Heart Rhythm."},{"key":"pmed.1003252.ref076","article-title":"QT Interval Prolongation and Torsade De Pointes in Patients with COVID-19 treated with","author":"E Chorin","year":"2020","journal-title":"Hydroxychloroquine\/Azithromycin. Heart Rhythm."},{"key":"pmed.1003252.ref077","author":"US Food","year":"2020","journal-title":"Memorandum Explaining Basis for Revocation of Emergency Use Authorization for Emergency Use of Chloroquine Phosphate and Hydroxychloroquine Sulfate"},{"key":"pmed.1003252.ref078","article-title":"Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study","author":"JCE Lane","year":"2020","journal-title":"medRxiv"},{"key":"pmed.1003252.ref079","article-title":"RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis","author":"MR Mehra","year":"2020","journal-title":"The Lancet"},{"key":"pmed.1003252.ref080","author":"James Watson on the behalf of 201 signatories","year":"2020","journal-title":"An open letter to Mehra et al and The Lancet (Version 4)"},{"issue":"8","key":"pmed.1003252.ref081","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1473-3099(18)30297-4","article-title":"Risk of sudden unexplained death after use of dihydroartemisinin\u2013piperaquine for malaria: a systematic review and Bayesian meta-analysis","volume":"18","author":"XHS Chan","year":"2018","journal-title":"The Lancet Infectious Diseases"},{"key":"pmed.1003252.ref082","first-page":"659","article-title":"Antiarrhythmics. I. Chloroquine in auricular fibrillation","volume":"43","author":"R Arora","year":"1955","journal-title":"Indian Journal of Medical Research"},{"issue":"6","key":"pmed.1003252.ref083","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/0002-8703(56)90159-4","article-title":"Chloroquine: Clinical and electrocardiographic observations after intravenous administration in two cases of auricular fibrillation","volume":"52","author":"L Sanghvi","year":"1956","journal-title":"American Heart Journal"},{"issue":"1","key":"pmed.1003252.ref084","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/01.RES.7.1.86","article-title":"Cardiovascular effects of chloroquine with special reference to its antifibrillatory action","volume":"7","author":"M Hess","year":"1959","journal-title":"Circulation Research"},{"issue":"6","key":"pmed.1003252.ref085","first-page":"295","article-title":"Antiarrhythmic potential of chloroquine: new use for an old drug","volume":"4","author":"L Harris","year":"1988","journal-title":"The Canadian Journal of Cardiology"},{"issue":"3","key":"pmed.1003252.ref086","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1161\/CIRCEP.111.966820","article-title":"Chloroquine terminates stretch-induced atrial fibrillation more effectively than flecainide in the sheep heart. Circulation","volume":"5","author":"D Filgueiras-Rama","year":"2012","journal-title":"Arrhythmia and Electrophysiology"},{"issue":"6","key":"pmed.1003252.ref087","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/europace\/eut290","article-title":"Evidence for cardiac safety and antiarrhythmic potential of chloroquine in systemic lupus erythematosus","volume":"16","author":"R Alkmim Teixeira","year":"2014","journal-title":"Europace"},{"issue":"2","key":"pmed.1003252.ref088","first-page":"191","article-title":"Effect of chloroquine in experimental myocardial ischaemia","volume":"72","author":"T Fazekas","year":"1988","journal-title":"Acta physiologica Hungarica"},{"issue":"12","key":"pmed.1003252.ref089","doi-asserted-by":"crossref","first-page":"e0143771","DOI":"10.1371\/journal.pone.0143771","article-title":"Hydroxychloroquine Protects against Cardiac Ischaemia\/Reperfusion Injury In Vivo via Enhancement of ERK1\/2 Phosphorylation","volume":"10","author":"L Bourke","year":"2015","journal-title":"PLoS ONE"},{"issue":"3","key":"pmed.1003252.ref090","doi-asserted-by":"crossref","first-page":"e1003040","DOI":"10.1371\/journal.pmed.1003040","article-title":"Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data","volume":"17","author":"XHS Chan","year":"2020","journal-title":"PLoS Med"},{"issue":"3","key":"pmed.1003252.ref091","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0035-9203(96)90241-2","article-title":"Electrocardiographic monitoring in severe falciparum malaria","volume":"90","author":"DB Bethell","year":"1996","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"7","key":"pmed.1003252.ref092","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan","volume":"5","author":"S Shi","year":"2020","journal-title":"China. JAMA Cardiology."},{"issue":"8979","key":"pmed.1003252.ref093","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0140-6736(95)92711-5","article-title":"Hypokalaemia related to acute chloroquine ingestion","volume":"346","author":"JL Clemessy","year":"1995","journal-title":"The Lancet"},{"issue":"9","key":"pmed.1003252.ref094","doi-asserted-by":"crossref","first-page":"678","DOI":"10.7326\/0003-4819-112-9-678","article-title":"Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus: a new job for an old drug?","volume":"112","author":"A Quatraro","year":"1990","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"pmed.1003252.ref095","doi-asserted-by":"crossref","first-page":"E897","DOI":"10.1152\/ajpendo.1991.260.6.E897","article-title":"Mode of action of chloroquine in patients with non-insulin-dependent diabetes mellitus","volume":"260","author":"J Powrie","year":"1991","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"issue":"4","key":"pmed.1003252.ref096","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0026-0495(93)90096-7","article-title":"Effects of chloroquine on the dyslipidemia of non-insulin-dependent diabetes mellitus","volume":"42","author":"J Powrie","year":"1993","journal-title":"Metabolism"},{"issue":"8","key":"pmed.1003252.ref097","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/ijd.14252","article-title":"Itching, chloroquine, and malaria: a review of recent molecular and neuroscience advances and their contribution to mechanistic understanding and therapeutics of chronic non-histaminergic pruritus","volume":"58","author":"AA Ajayi","year":"2019","journal-title":"International journal of dermatology"},{"issue":"5618","key":"pmed.1003252.ref098","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/bmj.3.5618.579","article-title":"Chloroquine: ophthalmological safety, and clinical assessment in rheumatoid arthritis","volume":"3","author":"S Percival","year":"1968","journal-title":"British Medical Journal"},{"issue":"12","key":"pmed.1003252.ref099","first-page":"1158","article-title":"Chloroquine retinopathy in the rhesus monkey.","volume":"17","author":"A Rosenthal","year":"1978","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"4","key":"pmed.1003252.ref100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9343(88)90358-0","article-title":"Ocular effects and safety of antimalarial agents","volume":"85","author":"M Easterbrook","year":"1988","journal-title":"The American Journal of Medicine"},{"issue":"2","key":"pmed.1003252.ref101","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/eye.2009.65","article-title":"Effects of chronic exposure to hydroxychloroquine or chloroquine on inner retinal structures","volume":"24","author":"S Pasadhika","year":"2010","journal-title":"Eye"},{"issue":"12","key":"pmed.1003252.ref102","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","article-title":"The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy","volume":"132","author":"RB Melles","year":"2014","journal-title":"JAMA Ophthalmology"},{"issue":"6","key":"pmed.1003252.ref103","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision)","volume":"123","author":"MF Marmor","year":"2016","journal-title":"Ophthalmology"},{"issue":"3","key":"pmed.1003252.ref104","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/08923973.2013.780078","article-title":"Chloroquine cardiomyopathy\u2013a review of the literature","volume":"35","author":"E T\u00f6nnesmann","year":"2013","journal-title":"Immunopharmacology and Immunotoxicology"},{"issue":"10","key":"pmed.1003252.ref105","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40264-018-0689-4","article-title":"Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature","volume":"41","author":"C Chatre","year":"2018","journal-title":"Drug Safety"},{"issue":"11","key":"pmed.1003252.ref106","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1182\/blood.V84.11.3613.bloodjournal84113613","article-title":"G6PD deficiency","volume":"84","author":"E Beutler","year":"1994","journal-title":"Blood"},{"issue":"21","key":"pmed.1003252.ref107","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM196811212792102","article-title":"Methemoglobinemia provoked by malarial chemoprophylaxis","volume":"279","author":"RJ Cohen","year":"1968","journal-title":"Vietnam. New England Journal of Medicine"},{"issue":"6","key":"pmed.1003252.ref108","doi-asserted-by":"crossref","first-page":"e008662","DOI":"10.1161\/CIRCEP.120.008662","article-title":"The Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection. Circulation","volume":"13","author":"M Saleh","journal-title":"Arrhythmia and Electrophysiology. 2020"},{"issue":"1","key":"pmed.1003252.ref109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198801073180101","article-title":"Treatment of severe chloroquine poisoning","volume":"318","author":"B Riou","year":"1988","journal-title":"New England Journal of Medicine"},{"issue":"31","key":"pmed.1003252.ref110","first-page":"1435","article-title":"Acute chloroquine poisoning","volume":"25","author":"J Clemessy","year":"1996","journal-title":"Presse Medicale (Paris, France: 1983)"},{"issue":"7","key":"pmed.1003252.ref111","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/00003246-199607000-00021","article-title":"Treatment of acute chloroquine poisoning: a 5-year experience","volume":"24","author":"JL Clemessy","year":"1996","journal-title":"Critical Care Medicine"},{"issue":"12","key":"pmed.1003252.ref112","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1007\/BF01709558","article-title":"Therapeutic trial of diazepam versus placebo in acute chloroquine intoxications of moderate gravity","volume":"22","author":"JL Clemessy","year":"1996","journal-title":"Intensive Care Medicine"},{"issue":"7","key":"pmed.1003252.ref113","first-page":"861","article-title":"Hydroxychloroquine overdose: toxicokinetics and management","volume":"37","author":"P Jordan","year":"1999","journal-title":"Journal of Toxicology: Clinical Toxicology"},{"issue":"7","key":"pmed.1003252.ref114","first-page":"712","article-title":"Hydroxychloroquine and cardiotoxicity: a retrospective review of regional poison center data","volume":"51","author":"N Cheema","year":"2013","journal-title":"Clinical Toxicology"},{"issue":"12","key":"pmed.1003252.ref115","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.ajem.2019.158387","article-title":"Toxicokinetics of hydroxychloroquine following a massive overdose","volume":"37","author":"J de Olano","year":"2019","journal-title":"The American Journal of Emergency Medicine"},{"issue":"5","key":"pmed.1003252.ref116","first-page":"311","article-title":"Chloroquine poisoning in Zimbabwe: a toxicoepidemiological study. Journal of Applied Toxicology","volume":"22","author":"D Ball","year":"2002","journal-title":"An International Journal"},{"key":"pmed.1003252.ref117","doi-asserted-by":"crossref","first-page":"e58631","DOI":"10.7554\/eLife.58631","article-title":"Concentration-dependent mortality of chloroquine in overdose","volume":"9","author":"JA Watson","year":"2020","journal-title":"Elife"},{"issue":"2","key":"pmed.1003252.ref118","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00007691-198506000-00013","article-title":"Chloroquine and desethylchloroquine in plasma, serum, and whole blood: problems in assay and handling of samples","volume":"7","author":"L Rombo","year":"1985","journal-title":"Therapeutic drug monitoring"},{"issue":"6","key":"pmed.1003252.ref119","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2125.1989.tb03439.x","article-title":"Bioavailability of hydroxychloroquine tablets in healthy volunteers","volume":"27","author":"S Tett","year":"1989","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"4","key":"pmed.1003252.ref120","doi-asserted-by":"crossref","first-page":"e208857","DOI":"10.1001\/jamanetworkopen.2020.8857","article-title":"Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial","volume":"3","author":"MGS Borba","year":"2020","journal-title":"JAMA Network Open."},{"issue":"6","key":"pmed.1003252.ref121","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1177\/0961203320912832","article-title":"Understanding the dynamics of hydroxychloroquine blood levels in lupus nephritis","volume":"29","author":"TN Pedrosa","year":"2020","journal-title":"Lupus"},{"issue":"9","key":"pmed.1003252.ref122","first-page":"1295","article-title":"Hydroxychloroquine serum concentrations and flares of systemic lupus erythematosus: a longitudinal cohort analysis. Arthritis Care &","volume":"68","author":"CC Mok","year":"2016","journal-title":"Research"},{"issue":"11","key":"pmed.1003252.ref123","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.3899\/jrheum.150379","article-title":"Hydroxychloroquine blood levels in systemic lupus erythematosus: clarifying dosing controversies and improving adherence","volume":"42","author":"L Durcan","year":"2015","journal-title":"The Journal of Rheumatology"},{"issue":"7","key":"pmed.1003252.ref124","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1177\/0961203319851558","article-title":"Association between hydroxychloroquine levels and disease activity in a predominantly Hispanic systemic lupus erythematosus cohort","volume":"28","author":"L Geraldino-Pardilla","year":"2019","journal-title":"Lupus"},{"issue":"9","key":"pmed.1003252.ref125","first-page":"1604","article-title":"Hydroxycloroquine blood concentration in lupus nephritis: a determinant of disease outcome?","volume":"33","author":"C Cunha","year":"2018","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"5","key":"pmed.1003252.ref126","doi-asserted-by":"crossref","first-page":"932","DOI":"10.4269\/ajtmh.20-0230","article-title":"A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19)","volume":"102","author":"M Keshtkar-Jahromi","year":"2020","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"pmed.1003252.ref127","article-title":"A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19","author":"DR Boulware","year":"2020","journal-title":"New England Journal of Medicine."},{"key":"pmed.1003252.ref128","article-title":"Hydroxychloroquine for the Prevention of Covid-19\u2014Searching for Evidence","author":"MS Cohen","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"pmed.1003252.ref129","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJMsb1901642","article-title":"The Magic of Randomization versus the Myth of Real-World Evidence","volume":"382","author":"R Collins","year":"2020","journal-title":"The New England Journal of Medicine"},{"key":"pmed.1003252.ref130","doi-asserted-by":"crossref","first-page":"m1335","DOI":"10.1136\/bmj.m1335","article-title":"Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence","volume":"369","author":"J Lenzer","year":"2020","journal-title":"BMJ"},{"key":"pmed.1003252.ref131","article-title":"Man Fatally Poisons Himself While Self-Medicating for Coronavirus, Doctor Says","author":"N Vigdor","year":"2020","journal-title":"New York Times"},{"key":"pmed.1003252.ref132","article-title":"Lupus patients hit by run on drug chloroquine after claims it wards against coronavirus","author":"TH Yee","year":"2020","journal-title":"Straits Times"},{"key":"pmed.1003252.ref133","article-title":"COVID-19 and risks to the supply and quality of tests, drugs, and vaccines","author":"PN Newton","year":"2020","journal-title":"The Lancet Global Health"},{"key":"pmed.1003252.ref134","author":"Indian Council for Medical Research","year":"2020","journal-title":"Recommendation for empiric use of hydroxychloroquine for prophylaxis of SARS-CoV-2 infection"}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1003445","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T10:59:57Z","timestamp":1668596397000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1003252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":134,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1003252","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pmed.1003445","asserted-by":"object"}]},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]}}}